Global Neisseria meningitidis Infections Drug Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Neisseria meningitidis Infections Drug Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Neisseria meningitidis Infections Drug Market Size Growth Rate by Product
  • 1.4.2 MGBBP-3
  • 1.4.3 NCL-195
  • 1.4.4 TP-10
  • 1.4.5 Others
• 1.5 Market by End User
  • 1.5.1 Global Neisseria meningitidis Infections Drug Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Neisseria meningitidis Infections Drug Market Size
  • 2.1.1 Global Neisseria meningitidis Infections Drug Revenue 2014-2025
  • 2.1.2 Global Neisseria meningitidis Infections Drug Sales 2014-2025
• 2.2 Neisseria meningitidis Infections Drug Growth Rate by Regions
  • 2.2.1 Global Neisseria meningitidis Infections Drug Sales by Regions
  • 2.2.2 Global Neisseria meningitidis Infections Drug Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Neisseria meningitidis Infections Drug Sales by Manufacturers
  • 3.1.1 Neisseria meningitidis Infections Drug Sales by Manufacturers
  • 3.1.2 Neisseria meningitidis Infections Drug Sales Market Share by Manufacturers
  • 3.1.3 Global Neisseria meningitidis Infections Drug Market Concentration Ratio (CR5 and HHI)
• 3.2 Neisseria meningitidis Infections Drug Revenue by Manufacturers
  • 3.2.1 Neisseria meningitidis Infections Drug Revenue by Manufacturers (2014-2019)
  • 3.2.2 Neisseria meningitidis Infections Drug Revenue Share by Manufacturers (2014-2019)
• 3.3 Neisseria meningitidis Infections Drug Price by Manufacturers
• 3.4 Neisseria meningitidis Infections Drug Manufacturing Base Distribution, Product Types
  • 3.4.1 Neisseria meningitidis Infections Drug Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Neisseria meningitidis Infections Drug Product Type
  • 3.4.3 Date of International Manufacturers Enter into Neisseria meningitidis Infections Drug Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Neisseria meningitidis Infections Drug Sales by Product
• 4.2 Global Neisseria meningitidis Infections Drug Revenue by Product
• 4.3 Neisseria meningitidis Infections Drug Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Neisseria meningitidis Infections Drug Breakdown Data by End User

6 North America

• 6.1 North America Neisseria meningitidis Infections Drug by Countries
  • 6.1.1 North America Neisseria meningitidis Infections Drug Sales by Countries
  • 6.1.2 North America Neisseria meningitidis Infections Drug Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Neisseria meningitidis Infections Drug by Product
• 6.3 North America Neisseria meningitidis Infections Drug by End User

7 Europe

• 7.1 Europe Neisseria meningitidis Infections Drug by Countries
  • 7.1.1 Europe Neisseria meningitidis Infections Drug Sales by Countries
  • 7.1.2 Europe Neisseria meningitidis Infections Drug Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Neisseria meningitidis Infections Drug by Product
• 7.3 Europe Neisseria meningitidis Infections Drug by End User

8 Asia Pacific

• 8.1 Asia Pacific Neisseria meningitidis Infections Drug by Countries
  • 8.1.1 Asia Pacific Neisseria meningitidis Infections Drug Sales by Countries
  • 8.1.2 Asia Pacific Neisseria meningitidis Infections Drug Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Neisseria meningitidis Infections Drug by Product
• 8.3 Asia Pacific Neisseria meningitidis Infections Drug by End User

9 Central & South America

• 9.1 Central & South America Neisseria meningitidis Infections Drug by Countries
  • 9.1.1 Central & South America Neisseria meningitidis Infections Drug Sales by Countries
  • 9.1.2 Central & South America Neisseria meningitidis Infections Drug Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Neisseria meningitidis Infections Drug by Product
• 9.3 Central & South America Neisseria meningitidis Infections Drug by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Neisseria meningitidis Infections Drug by Countries
  • 10.1.1 Middle East and Africa Neisseria meningitidis Infections Drug Sales by Countries
  • 10.1.2 Middle East and Africa Neisseria meningitidis Infections Drug Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Neisseria meningitidis Infections Drug by Product
• 10.3 Middle East and Africa Neisseria meningitidis Infections Drug by End User

11 Company Profiles

• 11.1 Beijing Minhai Biotechnology Co Ltd
  • 11.1.1 Beijing Minhai Biotechnology Co Ltd Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Products Offered
  • 11.1.5 Beijing Minhai Biotechnology Co Ltd Recent Development
• 11.2 Biological E Ltd
  • 11.2.1 Biological E Ltd Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Biological E Ltd Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Biological E Ltd Neisseria meningitidis Infections Drug Products Offered
  • 11.2.5 Biological E Ltd Recent Development
• 11.3 China National Pharmaceutical Group Corp
  • 11.3.1 China National Pharmaceutical Group Corp Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Products Offered
  • 11.3.5 China National Pharmaceutical Group Corp Recent Development
• 11.4 GlaxoSmithKline Plc
  • 11.4.1 GlaxoSmithKline Plc Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Products Offered
  • 11.4.5 GlaxoSmithKline Plc Recent Development
• 11.5 Griffith University
  • 11.5.1 Griffith University Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Griffith University Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Griffith University Neisseria meningitidis Infections Drug Products Offered
  • 11.5.5 Griffith University Recent Development
• 11.6 ImmunoBiology Ltd
  • 11.6.1 ImmunoBiology Ltd Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Products Offered
  • 11.6.5 ImmunoBiology Ltd Recent Development
• 11.7 JN-International Medical Corp
  • 11.7.1 JN-International Medical Corp Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 JN-International Medical Corp Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 JN-International Medical Corp Neisseria meningitidis Infections Drug Products Offered
  • 11.7.5 JN-International Medical Corp Recent Development
• 11.8 MGB Biopharma Ltd
  • 11.8.1 MGB Biopharma Ltd Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Products Offered
  • 11.8.5 MGB Biopharma Ltd Recent Development
• 11.9 Panacea Biotec Ltd
  • 11.9.1 Panacea Biotec Ltd Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Products Offered
  • 11.9.5 Panacea Biotec Ltd Recent Development
• 11.10 Pfizer Inc
  • 11.10.1 Pfizer Inc Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Pfizer Inc Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Pfizer Inc Neisseria meningitidis Infections Drug Products Offered
  • 11.10.5 Pfizer Inc Recent Development
• 11.11 Sanofi Pasteur SA
• 11.12 Serum Institute of India Ltd
• 11.13 Wellstat Vaccines LLC

12 Future Forecast

• 12.1 Neisseria meningitidis Infections Drug Market Forecast by Regions
  • 12.1.1 Global Neisseria meningitidis Infections Drug Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Neisseria meningitidis Infections Drug Revenue Forecast by Regions 2019-2025
• 12.2 Neisseria meningitidis Infections Drug Market Forecast by Product
  • 12.2.1 Global Neisseria meningitidis Infections Drug Sales Forecast by Product 2019-2025
  • 12.2.2 Global Neisseria meningitidis Infections Drug Revenue Forecast by Product 2019-2025
• 12.3 Neisseria meningitidis Infections Drug Market Forecast by End User
• 12.4 North America Neisseria meningitidis Infections Drug Forecast
• 12.5 Europe Neisseria meningitidis Infections Drug Forecast
• 12.6 Asia Pacific Neisseria meningitidis Infections Drug Forecast
• 12.7 Central & South America Neisseria meningitidis Infections Drug Forecast
• 12.8 Middle East and Africa Neisseria meningitidis Infections Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Neisseria meningitidis Infections Drug Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details